Understanding how menopause affects heart disease risk
Official title: A Longitudinal Study to Identify Mechanisms of Menopause on Cardiovascular Disease Risk
Run by University of Copenhagen · NCT05647876 · Data updated 2026-11-12
This study is trying to see how menopause affects heart disease risk in women by following them for at least 10 years and looking at changes in their heart and blood vessels.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 40 Years to 61 Years |
| Sex | Women only |
| Enrollment | 200 (estimated) |
| Sponsor | University of Copenhagen Academic / other |
| Locations | 1 site (Copenhagen) |
| Status | Recruiting |
| Started | December 16, 2022 |
| Main results expected | December 2040 |
| Study ends | August 2045 |
| Registry record updated | May 10, 2023 |
| Trial ID | NCT05647876 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women with regular menstruation who are approaching menopause.
✕Probably not a fit
Patients with chronic diseases, those on hormone therapy, or individuals with significant cardiovascular risk factors may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study will follow a cohort of 200 women from before menopause through at least 10 years post-menopause to investigate how the cessation of estrogen impacts cardiovascular disease risk. The study will utilize advanced invasive methodologies to monitor changes in blood vessels, the heart, and the brain, while also analyzing microRNA sequencing from blood and tissue samples. By examining these factors, the researchers aim to uncover the mechanisms linking menopause to increased cardiovascular risks.
Why it matters
Potential benefit: If successful, this study could lead to improved strategies for managing cardiovascular health in postmenopausal women.
How similar studies have gone: While there have been studies on menopause and cardiovascular health, this specific longitudinal approach focusing on microRNA and invasive methodologies is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Normal ECG * Regular menstruation Exclusion Criteria: * Participation in other clinical projects * Smokes or has smoked within the last 10 years * On hormone therapy * Has chronic diseases that are not expected, cf. the groups sought. Including heart problems, atrial fibrillation, cancer, immune diseases and previous strokes with functionally significant sequelae * Being treated with oral steroids * Has alcohol / drug abuse or is being treated with disulfiram (Antabus) * Is unable to understand the contents of the document with informed consent or the experimental procedures * Pregnancy or breastfeeding * Systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg * ovariectomy * BMI\>28
Where it's running
-
Deparment of Nutrition, Exercise and Sports
Copenhagen, Denmark Recruiting
Study contacts
- Principal investigator: Lasse Gliemann, PhD — Department of Nutrition, Exercise and Sports, University of Copenhagen, 2200 Copenhagen, Denmark
- Study coordinator: Lasse Gliemann, PhD
- Email: gliemann@nexs.ku.dk
- Phone: +4535321632
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using wearable data to improve cardiovascular risk predictions in women
This study is testing if information from wearable devices can help better predict heart disease risk in women aged 40-69 when usual health measurements aren't available.
-
Virtual registry for menopause and perimenopause in Australia
This study is creating an online registry to collect information from Australian women about their experiences with menopause and perimenopause to help improve healthcare and support for them.
-
Effects of Chardonnay marc on heart health
This study is testing whether eating products made with Chardonnay marc can improve heart health and how our bodies respond after meals.
-
Hop extract vs soy isoflavone for menopausal symptoms
This study tests whether a full-spectrum hop extract helps reduce menopausal mood symptoms better than soy isoflavones in peri- and postmenopausal women.
-
Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery
This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.
-
Resveratrol and Estrogen Receptors in Postmenopausal Women with CAD
This study tests whether taking resveratrol is safe and can change estrogen-related markers in postmenopausal women with coronary artery disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.